4AB:ETR
AbbVie Common Stock
233,10 €
arrow_downward
-0,43%(-1,00) 1 d.
6. okt., 16:55:20 GMT+2 · EUR
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: 4AB…
Atvērt
237,30 €
Augsta
238,00 €
Zema
233,10 €
Tirgus kapitalizācija
464,07 mljrd.
Vid. apjoms
664,00
Apjoms
870,00
Augstākā 52 ned.
238,00 €
Zemākā 52 ned.
162,85 €
Darbinieku skaits
57 tūkst.
Atvērt
237,30 €
Augsta
238,00 €
Zema
233,10 €
Tirgus kapitalizācija
464,07 mljrd.
Vid. apjoms
664,00
Apjoms
870,00
Augstākā 52 ned.
238,00 €
Zemākā 52 ned.
162,85 €
Darbinieku skaits
57 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
The Globe and Mail
·
pirms 35 minūtēm
Should You Buy AbbVie Stock Before Oct. 30?
Investing.com
·
pirms 1 stundas
UBS reiterates Abbvie stock rating on positive cancer trial data
Yahoo Finance UK
·
pirms 2 stundām
Wall Street Analysts See AbbVie (ABBV) as a Buy: Should You Invest?
Simply Wall Street
·
pirms 2 stundām
Did Frontline Lymphoma Trial Success Just Shift AbbVie (ABBV) Stock Narrative?
Profils
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
Par “AbbVie Common Stock”
ĢenerāldirektorsRobert A. Michael
Darbinieki57 tūkst.
Dibināšanas datums2012. gada 10. apr.
Galvenais birojsNorth Chicago, Ilinoisa, Amerikas Savienotās Valstis
Sektors-
Tīmekļa vietneabbvie.com